Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Anal Bioanal Chem. 2015 Jul 5;407(23):7239–7243. doi: 10.1007/s00216-015-8873-1

Fig. 3.

Fig. 3

Immunoarray and ELISA assay results from serum samples of cancer patients for (A) IL-6, (B) TNF-α, (C) CRP, and (D) IL-1β. S1–S4 corresponds to patient samples spiked with 50, 100, 200, and 500 pg mL-1 respectively. (*) corresponds to values below the detection limits of ELISA and (#) corresponds to values above the dynamic range of the microfluidic immunoarray.